Two people in President-elect Donald Trump's orbit have competing visions about how to address America's obesity epidemic, ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

If you are considering a natural over the counter Mounjaro alternative for 2025 - we have the top 3 options for you. SAN FRANCISCO, CA / ACCESSWIRE / December 18, 2024 / If you've been following ...

Maryland’s Medicaid program now offers partial coverage of popular obesity drugs, with the state spending more than $68 ...

News of Merck’s licensing of Hansoh’s preclinical medicine pressured shares in Viking and other obesity drug developers seen ...

Novo Holdings, the controlling shareholder of Novo Nordisk, on Wednesday sealed its $16.5 billion deal for Catalent, as the ...

Biden officials recently proposed allowing Medicare to start covering GLP-1 medications to treat obesity. It's unclear ...

Is it even possible to change lifestyles and the food environment enough to solve America’s obesity problem? And, if not, do ...

The European Union's drug regulator said it would review a potential link between Novo Nordisk's blockbuster diabetes drug, Ozempic, and a rare eye condition that causes vision loss after recent ...

But in an increasingly competitive market for weight loss drugs, these are not the only options for people looking to lose ...

The European Union's drug regulator said it would review two scientific studies that link Novo Nordisk's blockbuster diabetes drug Ozempic to a rare eye condition.

Pennsylvania's Medicaid spending per enrollee on Wegovy, Zepbound and other anti-obesity drugs was third-highest in the ...